OS Therapies (OSTX) Selling, General & Administrative (2023 - 2026)
OS Therapies' Selling, General & Administrative was $2.5 million in Q2 2026, up 6.9% from $2.34 million a year earlier but down 11.2% from the prior quarter.
Powered by 
Analysis
OS Therapies (OSTX) Selling, General & Administrative (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, OS Therapies' Selling, General & Administrative was $11.63 million through Jun 30, 2026, up 24.4% year-over-year; for FY2025, it came in at $12.34 million, up 210.6% from FY2024.
- In earlier years, Selling, General & Administrative was $3.97 million in FY2024 (+253.1%) and $1.13 million in FY2023.
- Quarterly Selling, General & Administrative has moved between $138,035 (Q4 2023) and $3.69 million (Q1 2025) over five years.
- Compared with a year earlier, Selling, General & Administrative was higher in five of the last six quarters, with growth averaging 222.0%.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2024 (growth of 631.8%); the worst was Q2 2024 (a decline of 26.7%).
- Per Business Quant data, OSTX's Selling, General & Administrative in the three quarters before Q2 2026 was $2.82 million (Q1 2026), $3.19 million (Q4 2025) and $3.12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | OS Therapies | 7.64 Mn | 7.64 Mn | - | 2.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.50 Mn |
| Mar 31, 2026 | 2.82 Mn |
| Dec 31, 2025 | 3.19 Mn |
| Sep 30, 2025 | 3.12 Mn |
| Jun 30, 2025 | 2.34 Mn |
| Mar 31, 2025 | 3.69 Mn |
| Dec 31, 2024 | 2.10 Mn |
| Sep 30, 2024 | 1.23 Mn |
| Jun 30, 2024 | 383,233.00 |
| Mar 31, 2024 | 268,423.00 |
| Dec 31, 2023 | 138,035.00 |
| Sep 30, 2023 | 167,703.00 |
| Jun 30, 2023 | 522,477.00 |
| Mar 31, 2023 | 294,247.00 |
API Access
OS Therapies Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=OSTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "OSTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=OSTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();